Wireless in vivo voltammetric measurements of neurotransmitters in freely behaving rats

Biosensors and Bioelectronics

Volumn 25, Issue 11, 2010, Pages 2425-2430

  Crespi, Francesco ^a  

^a GSK   (Italy)

Author keywords

Conscious behaving rat; Frontal cortex; In vivo voltammetry; Infrared transmission; Neurotransmitters; Telemetry

Indexed keywords

AMPEROMETRY; CHEMICAL NATURE; DIFFERENTIAL PULSE VOLTAMMETRY; DIRECT CURRENT; ELECTRODE SYSTEMS; ELECTROMAGNETIC INTERFERENCE; FLUOXETINE; FREELY MOVING; FRONTAL CORTEX; IN-VITRO; IN-VIVO; IN-VIVO EXPERIMENTS; IN-VIVO VOLTAMMETRY; MICROBIOSENSORS; PHARMACOLOGICAL TREATMENT; PREFRONTAL CORTEX; RADIO FREQUENCIES; TELEMETRIC SYSTEMS; TRANSMISSION CHANNELS; VOLTAMMETRIC MEASUREMENTS;

BIOELECTRIC PHENOMENA; BIOSENSORS; BRAIN; ELECTROMAGNETIC PULSE; FUZZY CONTROL; INFRARED TRANSMISSION; RADIO TRANSMISSION; RATS; STRUCTURAL DESIGN; TELEMETERING; TELEMETERING EQUIPMENT; VOLTAMMETRY;

RADIO BROADCASTING;

DOPAMINE; FLUOXETINE; NEUROTRANSMITTER; SEROTONIN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

AMPEROMETRY; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL PULSE VOLTAMMETRY; ELECTRODE; FRONTAL CORTEX; MALE; MOLECULAR INTERACTION; NONHUMAN; POTENTIOMETRY; RAT; SIGNAL TRANSDUCTION; TELEMETRY; WIRELESS IN VIVO POTENTIOMETRY; AMBULATORY MONITORING; ANIMAL; BRAIN; CONDUCTOMETRY; DEVICE FAILURE ANALYSIS; DEVICES; EQUIPMENT DESIGN; GENETIC PROCEDURES; METABOLISM; PHYSIOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ANIMALS; BEHAVIOR, ANIMAL; BIOSENSING TECHNIQUES; BRAIN; CONDUCTOMETRY; EQUIPMENT DESIGN; EQUIPMENT FAILURE ANALYSIS; MALE; MONITORING, AMBULATORY; NEUROTRANSMITTER AGENTS; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TELEMETRY;

RATTUS;

EID: 77953363076     PISSN: 09565663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bios.2010.03.034     Document Type: Article

References (42)

1. Annovazzi-Lodi V., Donati S. IEEE Trans. Biomed. Eng. 1988, 35:595-606.
2. Annovazzi-Lodi V., Donati S. IEEE Trans. Biomed. Eng. 1991, 38:212-214.
3. Butcher S.P., Fairbrother I.S., Kelly J.S., Arbuthnott G.W. J. Neurochem. 1988, 50(2):346-355.
4. Congestri F., Formenti F., Sonntag V., Crespi F. Sensors 2008, 8:6936-6951.
5. Crespi F. J. Neurosci. Methods 1990, 34:53-65.
6. Crespi F. Anal. Biochem. 1991, 194:1-8.
7. Crespi F. Neurosci. Lett. 1996, 215:189-192.
8. Crespi F. J. Neurosci. Methods 2002, 119:173-184.
9. Crespi F. Brain Res. 2009, 1281:35-46.
10. Crespi F., Sharp T., Maidment N., Marsden C.A. Neurosci. Lett. 1983, 43:203-207.
11. Crespi F., Jouvet M. Brain Res. 1984, 299:113-119.
12. Crespi F., Martin K.F., Marsden C.A. Neuroscience 1988, 27:885-896.
13. Crespi F., Martin K.F., Heal D.J., Marsden C.A., Buckett W.R., Sanghera M.K. Brain Res. 1989, 500:241-246.
14. Crespi F., Ratti E., Trist D.G. The Analyst 1994, 119:2193-2197.
15. Crespi F., Campagnola M., Neudeck A., McMillan K., et al. J. Neurosci. Methods 2001, 109:59-70.
16. Crespi F., D'Alessandro D., Annovazzi-Lodi V., Heidbreder C., Norgia M. J. Neurosci. Methods 2004, 140(1-2):153-161.
17. D'Alessandro, D., Annovazzi-Lodi, V., Crespi, F., 2002. Atti de 'Elettroottica 2002-VII Convegno Nazionale Strumentazione e Metodi di Misura Elettroottici', Montecatini Terme, 29-31 maggio 2002, pp. 303-306.
18. De Simoni M.G., De Luigi A., Imeri L., Algeri S. J. Neurosci. Methods 1990, 33:233-240.
19. Dugast, C., Suaud-Chagny, M.F., Gonon, F., 1994. Neuroscience 62, 647-654.
20. Fang M.A., Falk J.L., Lau C.E. Psychopharmacology 1999, 144:323-332.
21. Fischer J.F., Cho A.K. J. Pharmacol. Exp. Ther. 1979, 208:203-209.
22. Gonon F., Navarre F., Buda M. Anal. Chem. 1984, 56:573-575.
23. Hervas I., Artigas F. Eur. J. Pharmacol. 1998, 359:9-18.
24. Hervas I., Queiroz C.M.T., Adell A., Artigas F. Br. J. Pharmacol. 2000, 130:160-166.
25. Kagohashi M., Nakazato T., Yoshimi Y., Moizumi S., Hattori N., Kitazawa S. Neurosci. Res. 2008, 60:120-127.
26. Karoum F., Chrapusta S.J., Brinjak R., Hitri A., Wyatt R.J. Br. J. Pharmacol. 1994, 113(4):1391-1399.
27. Kawagge K.T., Wightman R.M. Talanta 1994, 41:865-874.
28. Imeri L., De Simoni M.G., Giglio R., Clavenna A., Mancia M. Neuroscience 1994, 58:353-358.
29. Jones S.R., Joseph J.D., Barak L.S., Caron M.G., Wightman R.M. J. Neurochem. 1999, 73:2406-2414.
30. Lau C.E., Sun L., Wang Q., Simpao A., Falk J.L. J. Pharmacol. Exp. Ther. 2000, 295:634-643.
31. Malagie' I., Trillat A.C., Jacquot C., Gardier A. Eur. J. Pharmacol. 1995, 286:213-217.
32. Martin K.F., Marsden C.A., Crespi F. Trends Anal. Chem. 1988, 7(9):334-339.
33. Nomikos G.G., Damsma G., Wenkstern D., Fibiger H.C. Synapse 1990, 6:106-112.
34. Roitman M.F., Stuber G.D., Phillips P.E.M., Wightman R.M., Carelli R.M. J. Neurosci. 2004, 24:1265-1271.
35. Romero L., Casanova J.M., Hervas I., Cortes R., Artigas F. Antidepressants: Current Trends and Future Directions 1997, 1-33. Humana Press, Totowa. P. Skolnick (Ed.).
36. Rossetti Z., Crespi F. Clin. Exp. Res. 2004, 28:1-6.
37. Stamford J., Crespi F., Marsden C.A. Practical Approach Series Monitoring Neuronal Activity 1992, Irl Press at Oxford University Press, Oxford, U.K., pp. 113-145.
38. Sulzer D., Maidment N.T., Rayport S. J. Neurochem. 1993, 60:527-535.
39. Tanda G., Pontieri F.E., Frau R., Di Chiara G. Eur. J. Neurosci. 1997, 9:2077-2085.
40. Wieczorek W.J., Kruk Z.L. Br. J. Pharmacol. 1994, 111:829-836.
41. Wolfe W.L. The IR Handbook 1978, Office of Naval Research, Washington. G.J. Zissis (Ed.).
42. Zetterström T., Sharp T., Collin A.K., Ungerstedt U. Eur. J. Pharmacol. 1988, 148(3):327-334.